Slate Path Capital LP - Q4 2019 holdings

$1.86 Billion is the total value of Slate Path Capital LP's 27 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 34.5% .

 Value Shares↓ Weighting
SNAP BuySNAP INCcl a$236,867,000
+3.8%
14,505,000
+0.5%
12.76%
-15.5%
CHTR SellCHARTER COMMUNICATIONS INC Ncl a$184,815,000
-4.4%
381,000
-18.8%
9.96%
-22.2%
GOLD  BARRICK GOLD CORPORATION$182,089,000
+7.3%
9,795,0000.0%9.81%
-12.7%
BHC NewBAUSCH HEALTH COS INC$166,952,0005,579,948
+100.0%
8.99%
NYT SellNEW YORK TIMES COcl a$158,598,000
+9.5%
4,930,000
-3.0%
8.54%
-10.9%
Z  ZILLOW GROUP INCcl c cap stk$134,375,000
+54.1%
2,925,0000.0%7.24%
+25.3%
KEX BuyKIRBY CORP$133,668,000
+19.2%
1,493,000
+9.4%
7.20%
-3.0%
MOS BuyMOSAIC CO NEW$132,437,000
+52.7%
6,120,000
+44.7%
7.13%
+24.2%
ALNY BuyALNYLAM PHARMACEUTICALS INC$93,864,000
+89.8%
815,000
+32.5%
5.06%
+54.4%
FCX BuyFREEPORT-MCMORAN INCcl b$91,578,000
+5073.9%
6,980,000
+3673.0%
4.93%
+4116.2%
PAAS  PAN AMERICAN SILVER CORP$85,284,000
+51.1%
3,600,0000.0%4.59%
+22.9%
MDCO SellMEDICINES CO$69,484,000
-62.4%
818,042
-77.9%
3.74%
-69.4%
EQT NewEQT CORP$54,173,0004,970,000
+100.0%
2.92%
SBGL BuySIBANYE STILLWATERsponsored adr$39,075,000
+189.9%
3,935,000
+57.6%
2.10%
+135.7%
RETA  REATA PHARMACEUTICALS INCcl a$24,532,000
+154.6%
120,0000.0%1.32%
+107.1%
EEM  ISHARES TRcall$14,942,000
+9.8%
333,0000.0%0.80%
-10.7%
CUE  CUE BIOPHARMA INC$14,129,000
+88.3%
890,0000.0%0.76%
+53.1%
QURE NewUNIQURE NV$10,032,000140,000
+100.0%
0.54%
ZG  ZILLOW GROUP INCcl a$8,462,000
+54.8%
185,0000.0%0.46%
+26.0%
INTEQ  INTELSAT S A$7,733,000
-69.2%
1,100,0000.0%0.42%
-74.9%
LX  LEXINFINTECH HLDGS LTDadr$3,125,000
+38.5%
225,0000.0%0.17%
+12.8%
TDW  TIDEWATER INC NEW$2,121,000
+27.6%
110,0000.0%0.11%
+3.6%
APRN  BLUE APRON HLDGS INCcl a new$2,106,000
-21.9%
320,0000.0%0.11%
-36.9%
AG  FIRST MAJESTIC SILVER CORP$2,084,000
+34.9%
170,0000.0%0.11%
+9.8%
SNAP  SNAP INCcall$1,796,000
+3.3%
110,0000.0%0.10%
-15.7%
ENDP NewENDO INTL PLC$1,642,000350,000
+100.0%
0.09%
X  UNITED STATES STL CORP NEW$456,000
-1.3%
40,0000.0%0.02%
-19.4%
MDRIQ ExitMCDERMOTT INTL INC$0-290,000
-100.0%
-0.04%
SDRLF ExitSEADRILL LTD$0-390,000
-100.0%
-0.05%
PDD ExitPINDUODUO INCsponsored ads$0-65,000
-100.0%
-0.14%
QQQ ExitINVESCO QQQ TRcall$0-21,000
-100.0%
-0.26%
CYCN ExitCYCLERION THERAPEUTICS INC$0-880,000
-100.0%
-0.71%
GE ExitGENERAL ELECTRIC CO$0-10,350,000
-100.0%
-6.13%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CHARTER COMMUNICATIONS INC N30Q3 202315.2%
ALNYLAM PHARMACEUTICALS INC30Q3 20208.9%
UNITED STATES STL CORP NEW24Q3 202311.4%
NEW YORK TIMES CO23Q3 202310.9%
VANECK VECTORS ETF TR21Q3 202319.5%
PAN AMERN SILVER CORP21Q3 20237.6%
CUE BIOPHARMA INC17Q3 20231.3%
BARRICK GOLD CORPORATION16Q4 202015.7%
MOSAIC CO NEW15Q4 202116.8%
MEDICINES CO15Q4 201912.2%

View Slate Path Capital LP's complete holdings history.

Latest significant ownerships (13-D/G)
Slate Path Capital LP Q4 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cue Biopharma, Inc.February 14, 20232,402,4555.6%
Stitch Fix, Inc.February 14, 2023? ?
Cyclerion Therapeutics, Inc.January 13, 20237,157,60116.5%
Zimmer Energy Transition Acquisition Corp.February 14, 20222,000,0005.8%
5:01 Acquisition Corp.February 11, 2022500,0005.8%
Hippo Holdings Inc.February 11, 2022350,0000.1%
Warner Music Group Corp.February 11, 20223,134,7792.6%
Reinvent Technology Partners ZFebruary 16, 20211,750,0007.6%

View Slate Path Capital LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-01-22
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G/A2023-02-14
SC 13G2023-02-14
13F-HR2023-02-14
SC 13G2023-01-13
SC 13G2022-11-18

View Slate Path Capital LP's complete filings history.

Compare quarters

Export Slate Path Capital LP's holdings